We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.75
Bid: 48.50
Ask: 49.00
Change: -0.50 (-1.02%)
Spread: 0.50 (1.031%)
Open: 48.00
High: 50.25
Low: 48.00
Prev. Close: 48.80
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Ten Entertainment, Emmerson chairs step down

Thu, 25th Mar 2021 15:57

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and not separately reported by Alliance News:

----------

Ten Entertainment Group PLC - Cranfield, England-based tenpin bowling operator - Nick Basing will step down as chair in September, after 6 years in the role and 12 with the company and its predecessor Essenden. Company has started the process of finding a replacement.

----------

Emmerson PLC - Khemisset potash project in northern Morocco - Mark Connelly retires as non-executive chair at general meeting, during which shareholders also approved Emmerson's move to AIM from the London Main Market, effective from Friday. Non-Executive Director James Kelly is promoted to independent non-executive chair.

----------

Ceres Power Holdings PLC - Horsham, West Sussex-based solid oxide fuel cell developer - Hires Tudor Brown as independent non-executive director, starting Thursday next week. Brown was among the founders of computer chip designer ARM Holdings PLC and served ARM as chief technology officer and chief operating officer. He is on the board of Hong Kong-listed personal computer and smart phone maker Lenovo Group Ltd.

----------

Atalaya Mining PLC - copper and silver mining in Spain - Jose Sierra will retire as an independent non-executive director on Wednesday next week, having served on the Atalaya board since 2011.

----------

Euromoney Institutional Investor PLC - London-based business media and events - Lorna Tilbian steps down as non-executive director, effective immediately, "to spend more time focusing on her other business interests".

----------

Biome Technologies PLC - Southampton, Hampshire-based biodegradable plastics and radio frequency systems - Hires Simon Herrick as non-executive director, joining immediately. Herrick is a non-executive director of London listings Ramsdens Holdings PLC and FireAngel Safety Technology Group PLC. As an executive, Herrick was chief financial officer for a number of companies, including department store chain Debenhams and Blancco Technology Group PLC. He will replace Michael Kayser as chair of the audit and remuneration committees when Kayser retires from the board at the Biome's annual general meeting on April 21.

----------

Avacta Group PLC - Wetherby, England-based developer of cancer immunotherapies - Mike Owen steps down as non-executive director, effective immediately, but remains chair of Avacta's scientific advisory board.

----------

Arrow Global Group PLC - European investor and alternative asset manager of loan portfolios - Appoints Davide Stecchi as managing director of Underwriting to lead the Arrow Capital Management underwriting team. Prior to joining Arrow, Stecchi spent 7 years at Hudson Advisors.

----------

Tirupati Graphite PLC - London-based graphite producer with operations in Madagascar and India - Strengthens its team across its three business units to support its growth. Appoints Biswal as head of the Tirupati Graphene & Mintech Research Centre. Names Sathpathy as an advisor to the company, specially focussed on application of graphene in aluminium manufacturing smelters and graphene aluminium composites development. Appoints Dash, who is also focused on graphene engineering science, to board.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
24 Feb 2021 10:25

AIM WINNERS & LOSERS: Mkango Hails Pilot Plant Processing Milestone

AIM WINNERS & LOSERS: Mkango Hails Pilot Plant Processing Milestone

Read more
22 Feb 2021 11:01

AIM WINNERS & LOSERS: Clear Leisure Surges Amid Placing, Bitcoin Plans

AIM WINNERS & LOSERS: Clear Leisure Surges Amid Placing, Bitcoin Plans

Read more
22 Feb 2021 09:28

Avacta Focusing On Full Clinical Validation Of Rapid Covid-19 Test

Avacta Focusing On Full Clinical Validation Of Rapid Covid-19 Test

Read more
22 Feb 2021 08:54

Avacta clarifies reports on potential use of its Covid-19 test

(Sharecast News) - Avacta Group responded to some press speculation on take-up of its lateral flow SARS-CoV-2 rapid antigen test for Covid-19 by the UK government on Monday.

Read more
22 Feb 2021 08:47

LONDON MARKET OPEN: European Equities Slip Amid Inflation Fears

LONDON MARKET OPEN: European Equities Slip Amid Inflation Fears

Read more
18 Feb 2021 14:31

IN BRIEF: Avacta Gets Phase I Clinical Trial Approval For AVA6000

IN BRIEF: Avacta Gets Phase I Clinical Trial Approval For AVA6000

Read more
18 Feb 2021 08:49

Avacta gets approval for first-in-human study of AVA6000

(Sharecast News) - Biotherapeutics and reagents developer Avacta has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) for a phase 1 study of its lead 'preCISION' pro-drug, AVA6000 pro-doxorubicin, it announced on Thursday.

Read more
16 Feb 2021 11:31

AIM WINNERS & LOSERS: Cornish Metals Jumps 40% On AIM Debut

AIM WINNERS & LOSERS: Cornish Metals Jumps 40% On AIM Debut

Read more
16 Feb 2021 09:48

Avacta Shares Surge On Positive Data For Covid-19 Antigen Test

Avacta Shares Surge On Positive Data For Covid-19 Antigen Test

Read more
16 Feb 2021 09:38

Avacta upbeat on initial data for Covid-19 rapid test study

(Sharecast News) - Biotherapeutics and reagents developer Avacta Group has received the first data for its SARS-CoV-2 rapid antigen test from ongoing clinical studies in Europe and the UK, it announced on Tuesday.

Read more
8 Feb 2021 11:25

Avacta enters commercial partnership with Mologic

(Sharecast News) - Biotherapeutics developer Avacta Group has entered into a commercial partnership with Mologic, it announced on Monday, to accelerate to market its 'AffiDX' SARS-CoV-2 lateral flow rapid antigen test.

Read more
8 Feb 2021 10:46

AIM WINNERS & LOSERS: Bahamas Petroleum Sinks As Pulls Plug On Well

AIM WINNERS & LOSERS: Bahamas Petroleum Sinks As Pulls Plug On Well

Read more
8 Feb 2021 09:37

Avacta Signs Agreement With Mologic For AffiDX Covid-19 Antigen Test

Avacta Signs Agreement With Mologic For AffiDX Covid-19 Antigen Test

Read more
1 Feb 2021 14:37

TRADING UPDATES: Asiamet Hits Back At Shareholder; Hardide Raises Cash

TRADING UPDATES: Asiamet Hits Back At Shareholder; Hardide Raises Cash

Read more
1 Feb 2021 09:25

Avacta joint venture with Daewoong raises $7.3m in series A funding

(Sharecast News) - Biotherapeutics developer Avacta Group announced on Monday that its joint venture with Daewoong Pharmaceutical, AffyXell Therapeutics, has closed a series A venture capital investment of $7.3m (£5.32m) to further develop its pipeline of next generation cell and gene therapies.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.